4//SEC Filing
BUNKA CHRISTOPHER 4
Accession 0001348362-25-000001
CIK 0001348362other
Filed
Jan 9, 7:00 PM ET
Accepted
Jan 10, 11:52 AM ET
Size
14.8 KB
Accession
0001348362-25-000001
Insider Transaction Report
Form 4
BUNKA CHRISTOPHER
DirectorChariman/CEO/President/CFO
Transactions
- Award
Restricted Stock Award
2025-01-07+100,000→ 373,543 total
Holdings
- 254,412(indirect: Private Holding Company)
common shares
- 6,667(indirect: Private Holding Company)
Warrants
Exercise: $10.50From: 2020-05-06Exp: 2025-05-06→ Common Shares (6,667 underlying) - 131,001
Stock Options
Exercise: $1.15From: 2023-10-26Exp: 2028-10-26→ Common Shares (30,000 underlying) - 180,501
Stock Options
Exercise: $2.36From: 2024-04-26Exp: 2029-04-26→ Common Shares (49,500 underlying) - 273,543
common shares
- 32,667
Stock Options
Exercise: $3.00From: 2021-04-26Exp: 2026-04-26→ Common Shares (26,000 underlying) - 56,001
Stock Options
Exercise: $3.00From: 2021-06-08Exp: 2026-06-08→ Common Shares (23,334 underlying) - 71,001
Stock Options
Exercise: $3.00From: 2021-09-01Exp: 2026-09-01→ Common Shares (15,000 underlying) - 101,001
Stock Options
Exercise: $2.91From: 2022-08-29Exp: 2027-08-29→ Common Shares (30,000 underlying)
Footnotes (2)
- [F1]Beneficial ownership reflects the aggregate securities held directly.
- [F2]The closing price on the Issuer's shares on the date of grant was $2.24.
Documents
Issuer
Lexaria Bioscience Corp.
CIK 0001348362
Entity typeother
Related Parties
1- filerCIK 0001103780
Filing Metadata
- Form type
- 4
- Filed
- Jan 9, 7:00 PM ET
- Accepted
- Jan 10, 11:52 AM ET
- Size
- 14.8 KB